We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Protest Higher Fees at Brazil’s ANVISA
Brazil’s Agência Nacional de Vigilância Sanitária is facing criticism from the medical device industry for hiking surveillance inspection fees as the country faces tough economic times.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor